Publications by authors named "Stuart John Forbes"

Claim this Profile
S
Semaphorin 7a is protective through immune modulation during acetaminophen-induced liver injury.
Eilidh J Livingstone, Jennifer A Cartwright, Lara Campana, Philip J Starkey Lewis, Benjamin J Dwyer, Stuart John Forbes

J Inflamm (Lond)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary cilia as a targetable node between biliary injury, senescence and regeneration in liver transplantation.
Hannah Esser, Alastair Morris Kilpatrick, Tak Yung Man, Rhona Aird, Daniel Rodrigo-Torres, Stuart John Forbes

J Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDGFRβ cells play a dual role as hematopoietic precursors and niche cells during mouse ontogeny.
Diana Sá da Bandeira, Alastair Morris Kilpatrick, Madalena Marques, Mario Gomez-Salazar, Telma Ventura, Stuart John Forbes

Cell Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternatively activated macrophages promote resolution of necrosis following acute liver injury.
Philip Starkey Lewis, Lara Campana, Niya Aleksieva, Jennifer Ann Cartwright, Alison Mackinnon, Stuart John Forbes

J Hepatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1.
Timothy James Kendall, Catherine Mary Duff, Luke Boulter, David H Wilson, Elisabeth Freyer, Stuart John Forbes

Nat Commun· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haematopoietic stem cells in cirrhosis - Authors' reply.
Philip Noel Newsome, Richard Fox, Stuart John Forbes

Lancet Gastroenterol Hepatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.
Philip Noel Newsome, Richard Fox, Andrew L King, Darren Barton, Nwe-Ni Than, Stuart John Forbes

Lancet Gastroenterol Hepatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis